RFID – the same wireless technology that can track pets or locate items – can also be used to measure breathing in patients with impaired lung function contactlessly – in hospital or at home.
Researchers have taken an early but promising step toward a cancer therapy that targets and destroys tumor cells with high precision, using a variant of the DNA editing tool CRISPR.
Being overweight can reduce vaccine effectiveness, new research finds. The findings explore differences in immune response, and may lead to more effective vaccines for patients with obesity.
New research reveals that extracellular vesicles derived from menstrual blood stromal cells can improve cartilage repair, suggesting an innovative cell-free therapy for osteoarthritis.
Researchers have developed a flexible optical fiber that can be threaded through a medical endoscope and steered into the larynx to destroy hard-to-reach tumors on the vocal folds.
To improve lung cancer detection, researchers have developed a new AI system that employs a dual approach to analyse CT scans – seeing both detail and context at the same time.
Scientists from the University of Maryland School of Medicine and colleagues create the first-ever immune-capable “Cervix-on-a-chip” to study sexually transmitted infections (STIs).
Researchers are developing a portable AI-powered scanning slit-light device, designed to make ophthalmic care more accessible, so patients can be assessed any place, and any time.
A tick's saliva keeps blood flowing, disarms the immune system, and smuggles in pathogens. Scientists have just found out how to disrupt this process and prevent infection.
Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.
A new type of “breathing” lung organoid enables quantitative measurement of how easily the lung expands - and may provide a new way to study diseases such as pulmonary fibrosis.
As women age, their breast tissue goes through major changes, with the most dramatic changes at menopause, but also during pregnancy and childbirth. A map reveals the impact on breast cancer.
Earlier detection, better outcomes: A new blood test for bowel cancer screening is designed to transform cancer outcomes by moving away from invasive or unpleasant methods.
A biomarker discovered in the cerebrospinal fluid could improve diagnosis of Parkinson's disease and dementia with Lewy bodies.
New treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and motor neurone disease (MND) could be unlocked thanks to microscopic medicines called intrabodies.
A new review shows that chronic stress may actively drive cancer progression. Therefore, psycho-oncology should be part of standard cancer care, the researchers argue.
A new X-ray imaging technique could transform how hospitals analyse tissue samples, potentially speeding up diagnoses and improving outcomes for patients, a new study shows.
Fear that their cancer will progress or worsen is one of the most common concerns among people living with this disease. A new tool aims to reliably measure patients’ anxiety about their cancer.
Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Using novel implantable neurotechnology and AI, researchers found a new way to make future leg prostheses feel and act more like a natural part of the body.
Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and the Atellica IM Brain Derived Tau (BDTau) assays. Both are run on the Atellica Solution IM and Atellica CI Analyzers.
Australian researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also delivering healing agents in one simple, scalable platform.
Why do some cancer cells develop treatment resistance? The answer may lie in hidden “storage hubs” inside tumour cells, which create uneven drug exposure across tumours, according to new research.
Early dysfunction of the glymphatic system — the network responsible for removing waste from the brain — could be a key vulnerability factor for the onset of psychosis, according to new research.
Glioblastoma is notorious for late diagnosis, rapid progression, resistance to treatment and its biological complexity. A new experimental method could help detect this deadly type of brain cancer.
